Sungmin Bae - Hanmi Pharmaceutical | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

HM16390, a Novel Long-Acting IL-2 Analog with Fine-Tuned Binding Affinities to IL-2 Receptor Subunits for Favorable Safety Profile, Exhibits Potent Tumor Killing Effect in the Various Tumor Syngeneic Models

Sol-Bi Shin,Jinyoung Kim,Jaehyuk Choi,Seongju Jeong, Yunjae Kim,Jooyun Byun,Sungmin Bae,Daejin Kim, In Young Choi

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

798-P: Potential Cardioprotective Effects of HM15275, a Novel, Long-Acting GLP-1/GIP/GCG Triple Agonist, in Animal Models of Hypertension

SEON MYEONG LEE,JUNG KUK KIM, EUNJIN PARK, HYE REYEON KANG,JEONG A. KIM, YOHAN KIM, SUNGHEE HONG,SUNGMIN BAE,SANG HYUN LEE,IN YOUNG CHOI

Diabetesno. Supplement_1 (2024)

引用0浏览0引用

Therapeutic Potential of HM15275, a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, in Animal Models of Heart Failure

Byeongjin Ye, Wonki Kim,Seon Myeong Lee,Jeong A. Kim, Eunseon Kim,Sungmin Bae, Sang Hyun Lee, In Young Choi

DIABETES (2024)

引用0浏览0引用

Nephroprotective Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Preclinical Models of Acute and Chronic Kidney Diseases

Seon Myeong Lee, Eunjin Park,Jung Kuk Kim, Hye Reyeon Kang,Jeong A. Kim, Yohan Kim, Sunghee Hong,Sungmin Bae, Sang Hyun Lee, In Young Choi

DIABETES (2024)

引用0浏览0引用

776-P: Potent Weight Loss and Favorable Glycemic Control Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Animal Models

SANG HYUN PARK, YOHAN KIM,JUNG KUK KIM, DAHAE LEE, EUNJIN PARK,JEONG A. KIM, SUNGHEE HONG,JAEHYUK CHOI,SUNGMIN BAE,SANG HYUN LEE,IN YOUNG CHOI

Diabetesno. Supplement_1 (2024)

引用0浏览0引用

1872-LB: Therapeutic Potential of HM15275, a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, in Animal Models of Heart Failure

B. Ye, W.K. Kim,SEON MYEONG LEE,JEONG A. KIM, Eung Ju Kim,SUNGMIN BAE,SANG HYUN LEE,IN YOUNG CHOI

Diabetesno. Supplement_1 (2024)

引用0浏览0引用

799-P: Nephroprotective Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Preclinical Models of Acute and Chronic Kidney Diseases

SEON MYEONG LEE,EUNJIN PARK,JUNG KUK KIM, HYE REYEON KANG,JEONG A. KIM,YOHAN KIM, SUNGHEE HONG,SUNGMIN BAE,SANG HYUN LEE,IN YOUNG CHOI

Diabetesno. Supplement_1 (2024)

引用0浏览0引用

Potential Cardioprotective Effects of HM15275, a Novel, Long-Acting GLP-1/GIP/GCG Triple Agonist, in Animal Models of Hypertension

Seon Myeong Lee,Jung Kuk Kim, Eunjin Park, Hye Reyeon Kang,Jeong A. Kim, Yohan Kim, Sunghee Hong,Sungmin Bae, Sang Hyun Lee, In Young Choi

DIABETES (2024)

引用0浏览0引用

Potent Weight Loss and Favorable Glycemic Control Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Animal Models

Sang Hyun Park, Yohan Kim,Jung Kuk Kim, Dahae Lee, Eunjin Park,Jeong A. Kim, Sunghee Hong,Jaehyuk Choi,Sungmin Bae, Sang Hyun Lee, In Young Choi

DIABETES (2024)

引用0浏览0引用

Cobalt(III)-induced Hexamerization of PEGylated Insulin

Sung In Lim,Myung Hyun Jang,Dae Jin Kim,Sung Min Bae,Se Chang Kwon

International Journal of Biological Macromolecules（2011）

引用3浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn